1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine

C109H122F18N36 — CID 158205951

IUPAC1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine
SMILESCC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4[nH]nc(N)c4c3)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4c(c3)c(N)cn4C)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4c(c3)c(N)nn4C)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4nc(N)nc(N)c4c3)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4ncnc(N)c4c3)c2C1.Cc1nc(N)c2cc(-n3nc(C(F)(F)F)c4c3CN(C(C)C)CC4)ccc2n1
InChIInChI=1S/C19H21F3N6.C19H22F3N5.C18H20F3N7.C18H21F3N6.C18H19F3N6.C17H19F3N6/c1-10(2)27-7-6-13-16(9-27)28(26-17(13)19(20,21)22)12-4-5-15-14(8-12)18(23)25-11(3)24-15;1-11(2)26-7-6-13-17(10-26)27(24-18(13)19(20,21)22)12-4-5-16-14(8-12)15(23)9-25(16)3;1-9(2)27-6-5-11-14(8-27)28(26-15(11)18(19,20)21)10-3-4-13-12(7-10)16(22)25-17(23)24-13;1-10(2)26-7-6-12-15(9-26)27(23-16(12)18(19,20)21)11-4-5-14-13(8-11)17(22)24-25(14)3;1-10(2)26-6-5-12-15(8-26)27(25-16(12)18(19,20)21)11-3-4-14-13(7-11)17(22)24-9-23-14;1-9(2)25-6-5-11-14(8-25)26(24-15(11)17(18,19)20)10-3-4-13-12(7-10)16(21)23-22-13/h4-5,8,10H,6-7,9H2,1-3H3,(H2,23,24,25);4-5,8-9,11H,6-7,10,23H2,1-3H3;3-4,7,9H,5-6,8H2,1-2H3,(H4,22,23,24,25);4-5,8,10H,6-7,9H2,1-3H3,(H2,22,24);3-4,7,9-10H,5-6,8H2,1-2H3,(H2,22,23,24);3-4,7,9H,5-6,8H2,1-2H3,(H3,21,22,23)
InChIKeyGBMOMDCXZWZCSN-UHFFFAOYSA-N
MW2278.39 g/mol
LogP19.41
Rot. Bonds12

About 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine

1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine (PubChem CID 158205951) has the molecular formula C109H122F18N36 and a molecular weight of 2278.39 g/mol. Its IUPAC name is 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine.

Molecular Properties

Compound Name1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine
PubChem CID158205951
Molecular FormulaC109H122F18N36
Molecular Weight2278.39 g/mol
Exact Mass2277.04
IUPAC Name1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine
SMILESCC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4[nH]nc(N)c4c3)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4c(c3)c(N)cn4C)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4c(c3)c(N)nn4C)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4nc(N)nc(N)c4c3)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4ncnc(N)c4c3)c2C1.Cc1nc(N)c2cc(-n3nc(C(F)(F)F)c4c3CN(C(C)C)CC4)ccc2n1
InChIInChI=1S/C19H21F3N6.C19H22F3N5.C18H20F3N7.C18H21F3N6.C18H19F3N6.C17H19F3N6/c1-10(2)27-7-6-13-16(9-27)28(26-17(13)19(20,21)22)12-4-5-15-14(8-12)18(23)25-11(3)24-15;1-11(2)26-7-6-13-17(10-26)27(24-18(13)19(20,21)22)12-4-5-16-14(8-12)15(23)9-25(16)3;1-9(2)27-6-5-11-14(8-27)28(26-15(11)18(19,20)21)10-3-4-13-12(7-10)16(22)25-17(23)24-13;1-10(2)26-7-6-12-15(9-26)27(23-16(12)18(19,20)21)11-4-5-14-13(8-11)17(22)24-25(14)3;1-10(2)26-6-5-12-15(8-26)27(25-16(12)18(19,20)21)11-3-4-14-13(7-11)17(22)24-9-23-14;1-9(2)25-6-5-11-14(8-25)26(24-15(11)17(18,19)20)10-3-4-13-12(7-10)16(21)23-22-13/h4-5,8,10H,6-7,9H2,1-3H3,(H2,23,24,25);4-5,8-9,11H,6-7,10,23H2,1-3H3;3-4,7,9H,5-6,8H2,1-2H3,(H4,22,23,24,25);4-5,8,10H,6-7,9H2,1-3H3,(H2,22,24);3-4,7,9-10H,5-6,8H2,1-2H3,(H2,22,23,24);3-4,7,9H,5-6,8H2,1-2H3,(H3,21,22,23)
InChIKeyGBMOMDCXZWZCSN-UHFFFAOYSA-N
XLogP19.41
TPSA437.27 Ų
H-Bond Donors8
H-Bond Acceptors35
Rotatable Bonds12
Heavy Atoms163
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002278.39
LogP ≤ 519.41
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1035

Analyze 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine?
The IUPAC name of 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine (CID 158205951) is 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine.
What is the SMILES notation for 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine?
The canonical SMILES for 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine is CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4[nH]nc(N)c4c3)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4c(c3)c(N)cn4C)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4c(c3)c(N)nn4C)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4nc(N)nc(N)c4c3)c2C1.CC(C)N1CCc2c(C(F)(F)F)nn(-c3ccc4ncnc(N)c4c3)c2C1.Cc1nc(N)c2cc(-n3nc(C(F)(F)F)c4c3CN(C(C)C)CC4)ccc2n1.
What is the InChIKey of 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine?
The InChIKey is GBMOMDCXZWZCSN-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H21F3N6.C19H22F3N5.C18H20F3N7.C18H21F3N6.C18H19F3N6.C17H19F3N6/c1-10(2)27-7-6-13-16(9-27)28(26-17(13)19(20,21)22)12-4-5-15-14(8-12)18(23)25-11(3)24-15;1-11(2)26-7-6-13-17(10-26)27(24-18(13)19(20,21)22)12-4-5-16-14(8-12)15(23)9-25(16)3;1-9(2)27-6-5-11-14(8-27)28(26-15(11)18(19,20)21)10-3-4-13-12(7-10)16(22)25-17(23)24-13;1-10(2)26-7-6-12-15(9-26)27(23-16(12)18(19,20)21)11-4-5-14-13(8-11)17(22)24-25(14)3;1-10(2)26-6-5-12-15(8-26)27(25-16(12)18(19,20)21)11-3-4-14-13(7-11)17(22)24-9-23-14;1-9(2)25-6-5-11-14(8-25)26(24-15(11)17(18,19)20)10-3-4-13-12(7-10)16(21)23-22-13/h4-5,8,10H,6-7,9H2,1-3H3,(H2,23,24,25);4-5,8-9,11H,6-7,10,23H2,1-3H3;3-4,7,9H,5-6,8H2,1-2H3,(H4,22,23,24,25);4-5,8,10H,6-7,9H2,1-3H3,(H2,22,24);3-4,7,9-10H,5-6,8H2,1-2H3,(H2,22,23,24);3-4,7,9H,5-6,8H2,1-2H3,(H3,21,22,23).
What are the key properties of 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine?
1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine has a molecular weight of 2278.39 g/mol, XLogP of 19.41, 12 rotatable bonds, 8 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indazol-3-amine;1-methyl-5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]indol-3-amine;2-methyl-6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;5-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]-1H-indazol-3-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazolin-4-amine;6-[6-propan-2-yl-3-(trifluoromethyl)-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-1-yl]quinazoline-2,4-diamine is sourced from PubChem (CID 158205951), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).